Pharmafocus
Pharmaceutical Industry news, analysis and insights
Jonathan Bowen from Sanofi UK and Ireland explains how indication-based agreements can remove barriers to patient access to combination cancer therapies
Giles Partington, Lindsay Govan, Paddy O’Hara, Emily Foreman and Jennifer Visser-Rogers from Phastar consider how data can be used to improve research innovations in rare diseases
Prof Shai Shen-Orr at Cytoreason explores the need for patient heterogeneity in drug development, and suggests why this is so central to successful drug development
Fiona Maini from Medidata Solutions, speaks about pharmaceutical regulation and the opportunities and policy challenges posed by digitalisation and a rapidly evolving industry
Michael Earl, director of pharmaceutical services at Owen Mumford, considers the benefits of connectivity and how this can be best utilised by pharma companies